Susan G. Komen @SusanGKomen · 02 Jun 2026
PANKU-Breast02 phase 3 trial: iza-bren vs chemo in pre-treated metastatic TNBC. Jiong Wu, MD, PhD reported that patients had improved overall survival & stayed progression-free longer w/ manageable side effects, suggesting iza-bren could become a new standard option @ASCO #ASCO26 https://t.co/vMRGcm1Nyp
647Views
5Likes
4Reposts
0Replies
0Quotes
1Bookmarks
Is that a lot?
0.03×vs 100K–1M median21 891 views is typical
0.62%Reachviews ÷ followers
1.39%Engagement rateof viewers reacted